Relapsed Small cell lung cancer
Also known as: Relapsed Small Cell Lung Cancer (SCLC)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11740 | Adavosertib | 1 | Completed | 1 |
| DB06186 | Ipilimumab | 1 | Terminated | 1 |
| DB12674 | Lurbinectedin | 1 | Terminated | 1 |
| DB09035 | Nivolumab | 1 | Terminated | 1 |
| DB09074 | Olaparib | 1 | Completed | 1 |
| DB16641 | Sugemalimab | 1 | Completed | 1 |
| DB00762 | Irinotecan | 1 / 2 | Withdrawn | 1 |
| DB11581 | Venetoclax | 1 / 2 | Withdrawn | 1 |
| DB11885 | Anlotinib | 2 | Recruiting | 1 |
| DB01248 | Docetaxel | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Terminated | 1 |
| DB00762 | Irinotecan | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Terminated | 1 |
| DB00762 | Irinotecan | 3 | Recruiting | 2 |
| DB12674 | Lurbinectedin | 3 | Recruiting | 1 |
| DB01030 | Topotecan | 3 | Recruiting | 2 |